|
Hormonal Replacement Therapy after Gynecologic Cancer Treatment |
|---|---|
| รหัสดีโอไอ | |
| Creator | Banthisa Somboon |
| Title | Hormonal Replacement Therapy after Gynecologic Cancer Treatment |
| Contributor | Yenrudee Poomtavorn |
| Publisher | PIMDEE Co., Ltd. |
| Publication Year | 2566 |
| Journal Title | Thai Journal of Obstetrics and Gynaecology |
| Journal Vol. | 31 |
| Journal No. | 2 |
| Page no. | 84-88 |
| Keyword | hormonal replacement therapy, gynecologic cancer, menopause |
| URL Website | https://tci-thaijo.org/index.php/tjog/index |
| Website title | www.tci-thaijo.org |
| ISSN | 2673-0871 |
| Abstract | Patients diagnosed with gynecologic cancers are principally managed by radiation, chemotherapy, and total hysterectomy with bilateral salpingo-oophorectomy. The resultant loss of ovarian function associated with gynecologic cancer treatments poses major health concerns as patients face the long-term effects of early menopause. The health implication entails vasomotor symptoms, osteoporosis, cognitive impairment, and increased cardiovascular risks, to name a few. Patients with gynecologic cancers are likely to require intervention, as loss of ovarian function due to cancer treatments tend to produce more severe symptoms than those from natural menopause. Hormonal replacement therapy (HRT) has shown to be an excellent option for treating menopausal symptoms. However, initiating HRT remains a challenge due to the expression of hormone receptors in most gynecologic cancers. This article aims to provide current evidence regarding HRT in managing menopause after gynecologic cancer treatment. |
